# NMDA Modulation in Major Depressive Disorder in Late- Life

> **NCT03414931** · PHASE2 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 136 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** NMDA
- **DRUG:** Sertraline
- **DRUG:** Placebo - Cap

## Key facts

- **NCT ID:** NCT03414931
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2020-11
- **Final completion:** 2020-11
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03414931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03414931, "NMDA Modulation in Major Depressive Disorder in Late- Life". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03414931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*